COPD Small Mobile Stem Cell Therapy Program
phase 1drug program · high
Develop an allogeneic Small Mobile Stem cell therapy for chronic obstructive pulmonary disease, with advancement toward U.S. clinical development and Phase 2.
Allogeneic cell therapy using adult stem cells derived from human blood through SMSbiotech's Small Mobile Stem cell platform.
Phase 1b showed early safety and encouraging efficacy signals; program is advancing toward U.S. clinical development and Phase 2.
Early Phase 1b results reportedly showed safety and encouraging efficacy signals.